CNTFR α Antibodies

Santa Cruz Biotechnology features a diverse variety of CNTFR α monoclonal antibodies for investigating CNTFR α protein function. CNTFR α monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).CNTFR α (Ciliary Neurotrophic Factor Receptor Alpha) plays a crucial role in the nervous system by mediating the effects of ciliary neurotrophic factor (CNTF), which is essential for the survival and differentiation of neurons. CNTFR α is involved in neuroprotection and has implications in neurodegenerative diseases, making it a significant target for research. Understanding CNTFR α function can provide insights into therapeutic strategies for conditions such as amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. Research utilizing CNTFR α monoclonal antibodies enables detailed investigation of neuronal signaling pathways. Studying CNTFR α expression patterns helps reveal its role in neural development and disease progression. CNTFR α research advances our understanding of potential therapeutic interventions for neurological conditions. Santa Cruz Biotechnology monoclonal antibodies for CNTFR α support researchers worldwide in advancing neuroscience discoveries and potential treatments for neurodegenerative diseases.